期刊文献+

盐酸度洛西汀的合成研究进展(待续) 被引量:3

Development in Synthesis Research of Duloxetine Hydrochloride (To be Continued)
在线阅读 下载PDF
导出
摘要 介绍了盐酸度洛西汀的特性和用途,叙述了近年来度洛西汀的13种合成方法,并评述了其优缺点。指出所有这些路线的主要区别在于调整了中间体的合成方法:将不能利用的(R)-中间体消旋,手性合成(S)-中间体,(R)-中间体制备盐酸度洛西汀。并认为应在2013年盐酸度洛西汀的物质专利到期前开发出一条有竞争力的路线,并提出了一条可能的路线。 The characteristics and use of duloxetine hydrochloride were introduced and 13 process methods of it in recent years and their advantages and disadvantages were reviewed in this paper.It was pointed out that the major difference in all the routes was the adjustment of the synthesis of intermediates,such as racemization of (r)-intemediate;asymmetric synthesis of (s)-intermediate;the preparation of duloxetine from (r)-intermediate.It was suggested to develop a new route before the expiration of the substance patent duration of duloxetine hydrochloride in 2013 and a possible route was advised.
作者 蒋祖林
出处 《化工生产与技术》 CAS 2009年第4期51-55,共5页 Chemical Production and Technology
关键词 盐酸度洛西汀 5-羟基色胺 抗抑郁药 去甲肾上腺素 duloxetine hydrochloride serotonin antidepressant drug norepinephrine
  • 相关文献

参考文献22

  • 1Rangaswamy S M, Jose M B, JoAnne E-J, et al. The World health report, 2001, Mental health: new understanding, new hope [R]. 1211 Geneva 27, Switzerland: World Health Organization, 2001:30.
  • 2雷旭伟,梁铁美.抗抑郁药物——盐酸度洛西汀[J].海峡药学,2008,20(4):93-94. 被引量:9
  • 3张建忠.国外抗抑郁药的进展及其国产化现状[J].上海医药,2003,24(6):270-273. 被引量:34
  • 4Berglund R A. Asymmetric synthesis of key intermediate in the synthesis of duloxetine via arylation of (S)-(- )-N,N- dimethyl-3-(2-thienyl)-3-hydroxy propanamine with 1- fluoronaphthalene in presence of potassium compound: US, 5362886[P]. 1994-11-08.
  • 5Robertson D W, Wong D T, Krushinski J H. Preparation of 3-aryloxy-3-substituted-propanamines as antidepressants: US, 5023269[P]. 1988-07-06.
  • 6Ramachandra R D, Narayanrao K R, Paul W C. A process of preparation of (+)-duloxetine: W0,2004056795 [P]. 2004- 07-08.
  • 7Berglund R A Impact of potassium sahs on aromatic substitution reactions [J]. Organic Process Research & Development, 1997(1): 328-330.
  • 8Jack D, Jeff F, Gilbert S, et al. Asymmetric synthesis and absolute stereochemistry of LY248686[J]. Tetrahedron Lett, 1990, 31(49): 7 101-7 104.
  • 9Staszak M A, Staten G S, Weigel L O. Chiral synthesis of 1- aryl-3 -aminopropan-l-ols: EP, 457559[P]. 1991-11-21.
  • 10Ahmed K, Ramesh K G B, Krishnaji R R. Chemoenzymatic synthesis of duloxetine and its enantiomer: lipase-catalyzed resolution of 3-hydroxy -3-(2-thienyl) propanenitrile [J]. Tetrahedron Lett, 2003,44(25): 4 783-4 787.

二级参考文献25

  • 1Holden C.Global survey examines impact of depression[J].Science,2000,288(5463):39-40.
  • 2Thor K B,Jennings D,Carmal I.Treatment of incontinence with venlafaxine or an aryloxy propanamine compound[P].EP:0 654 264,1994-11-22.
  • 3Greist J M D.Incidence and duration of antidepressant indusea nausea:duloxetine compared with paroxetine and fluoxetine[J].Clinical Therapaitics,2004,26(9):1446-1455.
  • 4Detke M J,Lu Y L,Goldstein D J,et al.Duloxetine 60mg once daily,for major depressive disorder:a randomized double-blind placebo-controlled trial[J].Journal of Clinical Psychiatry,2002,63(4):308-315.
  • 5Maurizio F.Somatic symptoms,depression and antidepressant tre-atment[J].Journal of Clinical Psychiatry,2002,63(4):305-307.
  • 6Lilly.Duloxetine oxalate[J].Drugs of Future,2000,25(9):907-916.
  • 7Ahmed K,Ramesh K G B,Ramu R,et al.Chemoenzymatic synthesis of duloxetine and its lipase-catalyzed resolution of 3-hydroxy-3-(2-thienyl)propanenitrile[J].Tetrahedron Letters,2003,44:4787.
  • 8Yamada Y,Hongo C,Shigeki R.Method for the racemization of optically active amino acids[J].J Org Chem,1983,48:846.
  • 9www. fda. gov
  • 10Chalon SA Granier LA, Vandenhende FR, et al. Duloxetine increases serotonin and norepinephrine availability in healthy Subjects:a doubleblind, controlled study [J]. Neuropsychopharmacology: 2003, 28 (9) : 1685- 1693.

共引文献42

同被引文献11

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部